We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Sony Invests Millions in Medical Devices and Clinical Pathology

By LabMedica International staff writers
Posted on 18 May 2012
Print article
The Israeli business daily Globes (Israel) reported that Sony Corporation (New York, NY, USA) is actively seeking to invest hundreds of millions of dollars in Israeli medical technologies. The consumer electronics company wants to create patient-friendly medical devices and diagnostic kits that will be used in point-of-care settings.

Sony is preparing for a major expansion into the world of medical devices, with a particular interest in medical laboratory testing and diagnostic test kits. Experts regard Sony’s new strategy as a sign that prospects in diagnostic testing remain strong.

This is a major strategy change for Sony. Company officials state that Sony will rely less on consumer electronics as it shifts its focus to healthcare sectors, in an effort to revive earnings

Sony is interested in the attractive business prospects for moving into healthcare. “As populations age, demand for medical devices rises, and we intend to participate in this,” declared Hiroshi Yoshioka, vice president, Sony, Inc., in the Globes article. The Globes story serves to demonstrate how the boundaries between consumer electronics and medical devices are blurring.

Recently, Sony applied for a patent that would use a wristband to monitor the heart rate, vital signs, and blood glucose levels of the wearer. This information would be transmitted to a compatible HDTV where the user could see this data. This would be transmitted to medical personnel if necessary.

The techno Website Engadget posted a news story about how Sony is combining medical device functions with consumer electronics. Pathologists and clinical laboratory managers will find the functions of Sony's patent to be very relevant to their work.

Sony is the latest corporate giant to recognize that it can benefit from the confluence of the fields of biotechnology, medical devices, high tech electronics, information technology, and telecommunications. These various technologies are being combined to create “smart” medical devices, according to BioDFW (Dallas, TX, USA, a life sciences regional alliance.

Related Links:

Globes
Sony Corporation
BioDFW

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.